CASSAVA SCIENCES INC (SAVA) Stock Balance Sheet
NASDAQ:SAVA - Nasdaq - US14817C1071 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 128.57M | 121.14M | 201.00M | 233.40M | 93.50M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | 947.00K | 962.00K | N/A | N/A | N/A | |||
| Other Current Assets | 7.01M | 7.54M | 10.30M | 11.10M | 500.00K | |||
| Total Current Assets | 136.53M | 129.63M | 211.20M | 244.50M | 94.00M | |||
| Non-Current Assets | ||||||||
| PPE Net | 20.96M | 21.85M | 23.00M | 20.80M | 300.00K | |||
| Intangibles | 37.00K | 176.00K | 600.00K | 1.10M | N/A | |||
| Other Non-Current Assets | N/A | N/A | 0.00 | 400.00K | N/A | |||
| Total Non-Current Assets | 21.00M | 22.03M | 23.60M | 22.30M | 300.00K | |||
| TOTAL ASSETS | 157.53M | 151.66M | 234.80M | 266.80M | 94.30M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 3.80M | 3.24M | 2.60M | 4.80M | 900.00K | |||
| Accounts Payable | 7.65M | 10.57M | 4.00M | 7.10M | 900.00K | |||
| Other Current Liabilities | 299.00K | 385.00K | 500.00K | 600.00K | 100.00K | |||
| Total Current Liabilities | 11.75M | 14.20M | 7.10M | 12.50M | 1.90M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 79.00K | 0.00 | 200.00K | 300.00K | 200.00K | |||
| Total Non-Current Liabilities | 79.00K | 0.00 | 200.00K | 400.00K | 200.00K | |||
| TOTAL LIABILITIES | 11.83M | 14.20M | 7.30M | 12.90M | 2.10M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -405.11M | -380.77M | -283.60M | -207.30M | -174.90M | |||
| Additional Paid In Capital | 550.77M | 518.20M | 511.00M | 461.20M | 267.10M | |||
| Common Shares | 48.00K | 42.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | N/A | N/A | N/A | N/A | N/A | |||
| Shares Outstanding | 48.20M | 42.24M | 41.70M | 40.00M | 35.20M | |||
| Tangible Book Value per Share | 3.02 | 3.25 | 5.44 | 6.32 | 2.62 | |||
| Total Shareholders' Equity | 145.70M | 137.47M | 227.50M | 253.90M | 92.20M | |||
| TOTAL LIABILITIES AND EQUITY | 157.53M | 151.66M | 234.80M | 266.80M | 94.30M | |||
| Statistics | ||||||||
| Current Ratio | 11.62 | 9.13 | 29.75 | 19.56 | 49.47 | |||
| Return On Assets (ROA) | -15.45% | -64.10% | -32.47% | -12.14% | -6.71% | |||
| Return On Equity (ROE) | -16.71% | -70.72% | -33.52% | -12.76% | -6.87% | |||
All data in USD , ROIC based on taxRate of 0.21